prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, Final Diagnosis. Breast, left, mastectomy: Infiltrating lobular carcinoma, Nottingham grade I (of III) [tubules 3/3,. nuclei 1/3, mitoses 1/3; Nottingham score 5/9], forming a mass (6.5 x 5.2 x 3.5 cm) located in the. superior portion of the breast [AJCC pT3]. Lobular carcinoma in situ (less than 5% of tumor. volume) is present. The non-neoplastic breast parenchyma shows nonproliferative fibrocystic. changes with duct ectasia. Calcifications are present in benign ducts and acini. The tumor does. not involve the nipple, overlying skin, or underlying chest wall. All surgical margins, including. the deep margin, are negative for tumor (minimum tumor free margin, 0.8 cm, deep margin). A. single (of 6) lymph node is positive for metastatic carcinoma [AJCC pN1]. Lymph node, left axillary, sentinel No. 1, excision: A single left axillary sentinel lymph node is. positive for metastatic carcinoma. Immunohistochemical cytokeratin stain was performed on the. paraffin embedded sentinel lymph node tissue and confirms the H&E impression. Blue dye is not. identified. Lymph node, left axillary sentinel No. 2, excision: A single left axillary sentinel lymph node is. negative for metastatic carcinoma. Immunohistochemical cytokeratin stain was performed on the. paraffin embedded sentinel lymph node tissue and confirms the H&E impression. Blue dye is. identified. Lymph node, left axillary, sentinel No. 3, excision: A single left axillary sentinel lymph node is. positive for metastatic carcinoma with a single focus measuring 0.9 cm in greatest dimensions. Blue dye is identified. Lymph nodes, left axillary, dissection: Multiple (6) axillary lymph nodes are negative for. metastatic carcinoma [AJCC pN1]. Estrogen and progesterone receptor analysis and Her-2/NEU have been ordered on paraffin. embedded tissue. Seen in consultation with Dr.

expanded version (tokens=878) : 
 Based on the breast pathology report, the following information can be extracted:

- Histological classification: Infiltrating lobular carcinoma and lobular carcinoma in situ.
- Subtype: LumA.
- Description of any necrosis: None mentioned.
- Tumor infiltrating lymphocytes: None mentioned.
- Histological grade: Nottingham grade I (of III) [tubules 3/3, nuclei 1/3, mitoses 1/3; Nottingham score 5/9].
- Nuclear grade: 1/3.
- Lymphovascular invasion: None mentioned.
- Calcification: Present in benign ducts and acini.
- Receptor status: Estrogen and progesterone receptor analysis and Her-2/NEU results are pending.
- IHC and any other ancillary testing results: Immunohistochemical cytokeratin stain was performed on the paraffin embedded sentinel lymph node tissue and confirms the H&E impression. Blue dye is identified in some sentinel lymph nodes.

The main points of the report are that the patient has infiltrating lobular carcinoma with lobular carcinoma in situ present in the left breast. The tumor has a histological grade of I and does not involve the nipple, overlying skin, or underlying chest wall. One lymph node is positive for metastatic carcinoma out of six that were examined. The surgical margins are negative for tumor, and non-neoplastic breast parenchyma shows nonproliferative fibroc

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1016) : 
 LumA subtype infiltrating lobular carcinoma with lobular carcinoma in situ. Histological grade I, no necrosis or lymphovascular invasion present. Positive axillary node out of six examined. Negative surgical margins, non-proliferative fibrocystic changes in the non-neoplastic tissue with calcifications present in benign ducts and acini. Estrogen and progesterone receptor analysis and Her-2/NEU pending.

